Novo Nordisk enters into research collaboration with Lumen Bioscience
The research-based collaboration will evaluate Lumen Bioscience's technology platform with the aim of creating oral medicines for obesity and other metabolic diseases.
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN
Novo Nordisk and Lumen Bioscience have entered into a research collaboration, according to a press release from the US company.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
